| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director | Chief Financial Officer +1 more
5 companies
Bjerkholt Eric serves as a Director at MBOT and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 16 buys and 18 sells. Those positions are worth an estimated $5.1M at current prices.
Historically, Bjerkholt Eric's trades have earned a strong insider score of 71/100 across 10 rated trades. Over a 12-month horizon, 57.1% of those trades were profitable, with an average 12-month return of +27.8%.
The biggest single holding is MIRM (~$4.4M) as Chief Financial Officer. The recent filings there lean toward selling, a net 39,283 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 9,943 | $98.37 | $978,092.91 | -18.2% | - | - | |
| Aug 11, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 6,001 | $99.90 | $599,509.50 | -14.2% | - | - | |
| Jul 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 5,000 | $122.25 | $611,273.24 | -10.6% | - | - | |
| Jun 9, 2026 | CERS Cerus Corporation | Director | Sell | 20,454 | $2.60 | $53,180.40 | -7.2% | - | - | |
| Jun 8, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 5,000 | $93.82 | $469,077.01 | -10.0% | - | - | |
| Mar 16, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 7,287 | $91.98 | $670,242.96 | -12.8% | +7.2% | - | |
| Jan 26, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 1,053 | $96.19 | $101,290.18 | -2.4% | - | - | |
| Jan 22, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 1,421 | $93.33 | $132,615.11 | -3.3% | - | - | |
| Sep 12, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 9,578 | $76.01 | $728,023.78 | -19.3% | -11.6% | - | |
| Aug 11, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 8,000 | $0.00 | - | -22.1% | +5.8% | - |